Related references
Note: Only part of the references are listed.The Changing Legal Landscape of Cannabis Use and Its Role in Youth-onset Psychosis
Abigail Wright et al.
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA (2020)
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders
Marie-Odile Krebs et al.
EUROPEAN JOURNAL OF PAIN (2019)
Comparison of Cortisol Stress Response in Patients with Panic Disorder, Cannabis-Induced Panic Disorder, and Healthy Controls
Katja Petrowski et al.
PSYCHOPATHOLOGY (2019)
Longitudinal Alterations in Prefrontal Resting Brain Connectivity in Non-Treatment-Seeking Young Adults With Cannabis Use Disorder
Jazmin Camchong et al.
FRONTIERS IN PSYCHIATRY (2019)
Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation
Roger Hudson et al.
JOURNAL OF NEUROSCIENCE (2019)
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
Abigail M. Freeman et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors
Hanna J. Szkudlarek et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Effects of increasing cannabis potency on adolescent health
Jack Wilson et al.
LANCET CHILD & ADOLESCENT HEALTH (2019)
Delta-9-tetrahydrocannabinol reduces the performance in sensory delayed discrimination tasks. A pharmacological-fMRI study in healthy volunteers
Carmen Walter et al.
IBRO REPORTS (2019)
The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors
Maurizio S. Riga et al.
NEUROPHARMACOLOGY (2018)
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Delta(9)-Tetrahydrocannabinol
Douglas L. Boggs et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex
Silvia Rigucci et al.
PSYCHOPHARMACOLOGY (2018)
Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons
Alex Straiker et al.
MOLECULAR PHARMACOLOGY (2018)
Impaired Cognitive Function after Perineuronal Net Degradation in the Medial Prefrontal Cortex
John W. Paylor et al.
ENEURO (2018)
Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments
Justine Renard et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function
Justine Renard et al.
SCIENTIFIC REPORTS (2017)
Chronic Adolescent Δ9-Tetrahydrocannabinol Treatment of Male Mice Leads to Long-Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol Treatment
Michelle Murphy et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controls
K. R. Engel et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2016)
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a NovelmTOR/p70S6Kinase Signaling Pathway
Justine Renard et al.
JOURNAL OF NEUROSCIENCE (2016)
Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System
Christopher Norris et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Association between genes on chromosome 19p13.2 and panic disorder
Noomi O. Gregersen et al.
PSYCHIATRIC GENETICS (2016)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome
Shaun A. Hussain et al.
EPILEPSY & BEHAVIOR (2015)
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-cannabinoid receptor in the ventral mesencephalon
Juliana Almeida da Silva et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
Chandni Hindocha et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Frontal cortex absolute beta power measurement in Panic Disorder with Agoraphobia patients
Marcele Regine de Carvalho et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2015)
The Contribution of Medial Prefrontal Cortical Regions to Conditioned Inhibition
Heidi C. Meyer et al.
BEHAVIORAL NEUROSCIENCE (2014)
NMDA and AMPA/Kainate Glutamatergic Receptors in the Prelimbic Medial Prefrontal Cortex Modulate the Elaborated Defensive Behavior and Innate Fear-Induced Antinociception Elicited by GABAA Receptor Blockade in the Medial Hypothalamus
Renato Leonardo de Freitas et al.
CEREBRAL CORTEX (2014)
PANIC DISORDER AND AGORAPHOBIA: AN OVERVIEW AND COMMENTARY ON DSM-5 CHANGES
Gordon J. G. Asmundson et al.
DEPRESSION AND ANXIETY (2014)
The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs
Maurizio S. Riga et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area
Brittany Draycott et al.
JOURNAL OF NEUROSCIENCE (2014)
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats
Erica Zamberletti et al.
NEUROBIOLOGY OF DISEASE (2014)
Prefrontal Cortical GABA Transmission Modulates Discrimination and Latent Inhibition of Conditioned Fear: Relevance for Schizophrenia
Patrick T. Piantadosi et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor
Renato Leonardo de Freitas et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Prefrontal cortex and neural mechanisms of executive function
Shintaro Funahashi et al.
JOURNAL OF PHYSIOLOGY-PARIS (2013)
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae)
Andre Twardowschy et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Decreased GABA levels in anterior cingulate cortex/medial prefrontal cortex in panic disorder
Zaiyang Long et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats
Alline Cristina Campos et al.
PSYCHOPHARMACOLOGY (2013)
Effects of Δ9-Tetrahydrocannabinol on Human Working Memory Function
Matthijs G. Bossong et al.
BIOLOGICAL PSYCHIATRY (2012)
Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users
Marta Di Forti et al.
BIOLOGICAL PSYCHIATRY (2012)
Early Prefrontal Functional Blockade in Rats Results in Schizophrenia-Related Anomalies in Behavior and Dopamine
Francisca Meyer et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
Victoria S. Dalton et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors
Vanessa de Paula Soares et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Lesions to the ventral, but not the dorsal, medial prefrontal cortex enhance latent inhibition
David N. George et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Role of extracellular signal-regulated kinase signal transduction pathway in anxiety
Fu Ailing et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity
Marcia D. Antion et al.
LEARNING & MEMORY (2008)
Regulatory mechanisms of fear extinction and depression-like behavior
Natalie C. Tronson et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Perceptual functions of perirhinal cortex in rats: Zero-delay object recognition and simultaneous oddity discriminations
Susan J. Bartko et al.
JOURNAL OF NEUROSCIENCE (2007)
Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample
Michael J. Zvolensky et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2006)
Anxiety sensitivity interacts with marijuana use in the prediction of anxiety symptoms and panic-related catastrophic thinking among daily tobacco users
Michael J. Zvolensky et al.
BEHAVIOUR RESEARCH AND THERAPY (2006)
Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs
Steven R. Laviolette et al.
JOURNAL OF NEUROSCIENCE (2006)
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
AW Zuardi et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
DC D'Souza et al.
BIOLOGICAL PSYCHIATRY (2005)
Modulation of extracellular signal-regulated kinases cascade by chronic Δ9-tetrahydrocannabinol treatment
T Rubino et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2004)
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
DC D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
The 'two-headed' latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment
I Weiner
PSYCHOPHARMACOLOGY (2003)
Inhibition of ongoing responses following frontal, nonfrontal, and basal ganglia lesions
M Rieger et al.
NEUROPSYCHOLOGY (2003)
Disruption and Potentiation of latent inhibition by risperidone: The latent inhibition model of atypical antipsychotic action
I Weiner et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction
DW Volk et al.
PHYSIOLOGY & BEHAVIOR (2002)
The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer's disease
LE Schechter et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
The phosphoinositide 3-kinase and p70 S6 kinase regulate long-term potentiation in hippocampal neurons
CR Raymond et al.
NEUROSCIENCE (2002)
Involvement of the serotonergic type 1A (5-HT1A) receptor in the agranular insular cortex in the consolidation of memory for inhibitory avoidance in rats
TME Souza et al.
BEHAVIOURAL PHARMACOLOGY (2001)
An integrative theory of prefrontal cortex function
EK Miller et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Share Paper
